Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,300
Closed -$1.89M 1184
2021
Q4
$1.89M Sell
18,300
-25,700
-58% -$2.79M ﹤0.01% 856
2021
Q3
$4.5M Sell
44,000
-25,859
-37% -$2.32M 0.01% 706
2021
Q2
$6.66M Sell
69,859
-26,600
-28% -$2.58M 0.02% 635
2021
Q1
$7.88M Buy
96,459
+93,400
+3,053% +$7.53M 0.02% 571
2020
Q4
$208K Buy
+3,059
New +$191K ﹤0.01% 1167
2017
Q2
Sell
-196,688
Closed -$4.41M 1241
2017
Q1
$4.41M Sell
196,688
-25,200
-11% -$500K 0.02% 622
2016
Q4
$3.79M Buy
221,888
+42,000
+23% +$632K 0.02% 634
2016
Q3
$2.45M Buy
179,888
+82,560
+85% +$1.04M 0.01% 711
2016
Q2
$1.09M Buy
+97,328
New +$1.02M ﹤0.01% 851

Other funds holding AZTA

Axa's AZTA Position: Q1 2022 in Review

Axa sold out of Azenta (AZTA) in Q1 2022, closing a stake of 18,300 shares — an estimated $1.89M sold.

Axa first reported a position in AZTA in Q2 2016 and held it in 9 quarters. The position peaked at $7.88M in Q1 2021. 383 funds tracked by Wall St. Rank hold AZTA as of Q1 2022.

  • Axa reported no remaining Azenta position as of Q1 2022 after selling out during the quarter.
  • Axa sold 18,300 Azenta shares in Q1 2022, an estimated $1.89M.
  • Axa first reported a position in Azenta in Q2 2016 and held it in 9 quarters.
  • Axa's Azenta position peaked at $7.88M in Q1 2021.
  • 383 funds tracked by Wall St. Rank held Azenta as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.